NFKB1 and psoriasis: TNF-alpha inhibitors thus work by blocking the action of TNF-alpha and preventing it from interacting with other cellular pathways, including the NF-kB pathway [4]. NF-kB signaling is an important inflammatory pathway that regulates the expression of genes involved in immune response and has been frequently associated with the pathogenesis of psoriasis.